BioPharma Dive - Latest News

Mixed COPD results for Regeneron, Sanofi drug cloud approval chances

Results released Friday show itepekimab succeeded in one Phase 3 trial but failed in a second, sinking shares of both partner companies.

May 30, 2025 - 16:10
 0
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances

Results released Friday show itepekimab succeeded in one Phase 3 trial but failed in a second, sinking shares of both partner companies.

Read More

Tags:

Previous Article

Keros lays off nearly half its staff; Astellas buys into a China biotech’s ADC

Next Article

Longer In-Bed Time Linked to Small Vessel Disease Burden in TIA/Mild Stroke

Related Posts

FDA delays approval decision for Biohaven rare disease drug

FDA delays approval decision for Biohaven rare disease ...

May 15, 2025  0

From insight to impact: How eCOAs strengthen trial data quality

From insight to impact: How eCOAs strengthen trial data...

May 19, 2025  0

FDA sets COVID vaccine formula as RFK Jr. narrows guidance for shots

FDA sets COVID vaccine formula as RFK Jr. narrows guida...

May 27, 2025  0